Bleeding complications in patients with squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

Bleeding complications in patients with squamous cell carcinoma of the head and neck

Published:2021-06-12 Issue:9 Volume:43 Page:2844-2858
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Bergamini Cristiana¹^ORCID,Ferris Robert L.²,Xie Jing³,Mariani Gabriella⁴,Ali Muzammil⁵,Holmes William C.⁵,Harrington Kevin⁶,Psyrri Amanda⁷,Cavalieri Stefano¹^ORCID,Licitra Lisa¹⁸

Affiliation:

1. Head and Neck Medical Oncology Unit Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

2. Department of Otolaryngology UPMC Hillman Cancer Center Pittsburgh Pennsylvania USA

3. Department of Epidemiology AstraZeneca Gaithersburg Maryland USA

4. Global Medicine Development AstraZeneca Cambridge UK

5. Global Medicine Development AstraZeneca Gaithersburg Maryland USA

6. The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust National Institute of Health Research Biomedical Research Centre London UK

7. Section of Medical Oncology, Department of Internal Medicine Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens Athens Greece

8. Department of Oncology and Hemato‐Oncology University of Milan Italy

Funder

AstraZeneca

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26772

Reference56 articles.

1. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

2. Management of Bleeding in Patients with Advanced Cancer